Recent studies have shown that Myc activation implicates the pathway in renal fibrosis and in the progression of AKI to CKD [23, 24], and Myc could be a potential therapeutic target in tubulointerstitial diseases [25]. This evidence concerns the gene MYC and acute kidney injury.